Disease Landscape

Alzheimer's Disease Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
879
Active Trials
510
Recruiting
71
Phase 3
485
Sponsors
110
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-15 NCT06112860
OTC Hearing Aid and MCI · Northwestern University
date change Completion pushed: 2026-12-31 -> 2027-03-30
2026-08-15 NCT05372159
Vanderbilt Memory and Aging Project · Vanderbilt University Medical Center
Enrollment closed, study ongoing
2026-08-15 NCT05372159
Vanderbilt Memory and Aging Project · Vanderbilt University Medical Center
date change Primary completion pushed: 2026-12-31 -> 2027-12-31
2026-08-15 NCT05372159
Vanderbilt Memory and Aging Project · Vanderbilt University Medical Center
date change Completion pushed: 2026-12-31 -> 2027-12-31
2026-08-15 NCT05617014
Alzheimer's Disease Neuroimaging Initiative 4 · University of Southern California
Trial sites expanded: 62 -> 65 locations
2026-08-14 NCT06808984
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment… · Celgene
Trial sites expanded: 53 -> 75 locations
2026-08-14 NCT07213700
InRAD Observational Study · Stichting International Registry for Alzheimer's Disease and other Dementias Foundation
Trial sites expanded: 7 -> 11 locations
2026-08-13 NCT07752784
Evaluate the Concordance Between PET Imaging of [18F]-APN-1607 Injection and Postmortem… · JYAMS PET Research & Development Limited
Enrolling by invitation only
2026-08-13 NCT07752784
Evaluate the Concordance Between PET Imaging of [18F]-APN-1607 Injection and Postmortem… · JYAMS PET Research & Development Limited
date change Primary completion pushed: 2026-12-31 -> 2027-04-30
2026-08-13 NCT07752784
Evaluate the Concordance Between PET Imaging of [18F]-APN-1607 Injection and Postmortem… · JYAMS PET Research & Development Limited
date change Completion pushed: 2027-04-07 -> 2027-08-15
2026-08-13 NCT07636811
A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down… · Alnylam Pharmaceuticals
Recruitment opened
2026-08-12 NCT07174869
A Study To Assess The Feasibility Of Indivi Mobile Application In Monitoring Cognitive… · Indivi AG
Trial completed
2026-08-12 NCT07174869
A Study To Assess The Feasibility Of Indivi Mobile Application In Monitoring Cognitive… · Indivi AG
Enrollment reduced: 55 -> 32 participants
2026-08-12 NCT07174869
A Study To Assess The Feasibility Of Indivi Mobile Application In Monitoring Cognitive… · Indivi AG
date change Primary completion pushed: 2026-06 -> 2026-07-09
2026-08-12 NCT07174869
A Study To Assess The Feasibility Of Indivi Mobile Application In Monitoring Cognitive… · Indivi AG
date change Completion pushed: 2026-06 -> 2026-07-09
2026-08-11 NCT05531656
A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease · Cognition Therapeutics
date change Primary completion pushed: 2027-04 -> 2027-05-31
2026-08-11 NCT05531656
A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease · Cognition Therapeutics
date change Completion pushed: 2027-04 -> 2027-05-31
2026-08-11 NCT06209515
Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease… · Kuopio University Hospital
date change Primary completion pushed: 2027-12-31 -> 2029-12-31
2026-08-11 NCT06209515
Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease… · Kuopio University Hospital
date change Completion pushed: 2027-12-31 -> 2029-12-31
2026-08-11 NCT07279103
Multisensory Environment-Based Occupational Therapy for Alzheimer's Patients · Hacettepe University
overall status: Enrolling by Invitation → Completed
Showing 20 of 110 changes detected in the last 30 days.
New Sponsor Entrants, Last 90 Days
First PostedTrialSponsorPhase
2026-08-14 NCT07764679 A Clinical Study Evaluating the Diagnostic Performance and Safety of PET for the… HTA Co., Ltd. NEW Phase 3
2026-08-13 NCT07764185 Caring Recharge Project for Caregivers of Individuals With Alzheimer's Disease Photozig, Inc. NEW Phase 2
2026-08-13 NCT07763392 Establishing Normal Cognitive Test Scores for Adults Using a Voice-Enabled Digital… The Neurology Center of Southern California NEW
2026-08-11 NCT07758660 Alzheimer's Disease Research Center (ADRC) PET Component Study Patrick Lao NEW Phase 2
2026-08-11 NCT07757178 Lived Experience Narratives in Dementia University of Nottingham NEW
2026-08-03 NCT07741526 Safety, Tolerability and Biomarker-based Efficacy of NPI-001 (AT-001) in Subjects With… Arctic Therapeutics NEW Phase 2
2026-08-03 NCT07741071 N-AD: Orally Administered Nicotinamide Riboside Over Two Years as a Potential Disease… Haukeland University Hospital NEW Phase 2
2026-07-29 NCT07732842 Study of Repetitive Behaviors in Alzheimer's Disease Centre Hospitalier Esquirol NEW
2026-07-28 NCT07731191 Digital Solutions for Predicting the Biological Mechanisms of Alzheimer's Disease Through… IRCCS Centro San Giovanni di Dio Fatebenefratelli NEW
2026-07-23 NCT07721467 Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin National Institute on Aging (NIA) NEW Phase 2
Active Trials by Phase
Phase 4
16
Phase 3
57
Phase 2/3
14
Phase 2
101
Phase 1/2
27
Phase 1
57
Early Phase 1
15
Not specified
592
Active Trials — top 25 of 879
NCT IDTitleSponsorStatus
Phase 4
NCT03082755 Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease University of Texas at Austin Recruiting
NCT05908695 An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of… Green Valley (Shanghai) Pharmaceuticals Co., Ltd. Recruiting
NCT03821857 Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease Mayo Clinic Recruiting
NCT05004987 Aβ Dynamics in LLMD NYU Langone Health Recruiting
NCT07604896 Evaluating the Efficacy and Safety of Lecanemab in Alzheimer's Disease Through… First Affiliated Hospital of Wenzhou Medical University Recruiting
NCT05924425 Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to… University Hospital, Montpellier Recruiting
NCT07688460 Evaluation System for Lecanemab Efficacy Using Gold Electrode ECL to Monitor Alzheimer's… The Fourth Affiliated Hospital of Zhejiang University School of Medicine Recruiting
NCT07633470 A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver… Alpha Cognition, Inc Recruiting
NCT03454646 Comparison of Therapeutic Strategies With Cholinesterase Inhibitors (SOS TRIAL) University Hospital, Bordeaux Not Yet Recruiting
NCT05181475 Long-term Efficacy and Safety Study of GV-971 Green Valley (Shanghai) Pharmaceuticals Co., Ltd. Active, Not Recruiting
NCT05058040 A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971) Green Valley (Shanghai) Pharmaceuticals Co., Ltd. Active, Not Recruiting
NCT05586750 Statins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy Monash University Active, Not Recruiting
NCT07034222 12-Month Real-World Safety & Efficacy of Lecanemab in Early Alzheimer's Disease Ruijin Hospital Active, Not Recruiting
NCT06911944 Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation Michael Rafii, MD, PhD Not Yet Recruiting
NCT00950430 Imaging of Brain Amyloid Plaques in the Aging Population Mayo Clinic Enrolling by Invitation
NCT07579689 Effects of Ginkgo Biloba on Blood Biomarkers in Mild Cognitive Impairment Hanyang University Not Yet Recruiting
Phase 3
NCT03848312 Preventing Alzheimer's With Cognitive Training University of South Florida Recruiting
NCT06530732 Deep Cervical Lymphatlc-Venous Anastomosis Surgery for the Treatment of Alzheimer's… Zhejiang Provincial People's Hospital Recruiting
NCT06702124 A Phase 3 Study of Rotigotine in Combination with Rivastigmine in Mild to Moderate… I.R.C.C.S. Fondazione Santa Lucia Recruiting
NCT06254469 Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of… CereMark Pharma, LLC Recruiting
NCT07115238 Analysis of 18F-XTR006 PET Imaging in Cognitively Normal Subjects, and Patients With MCI… Sinotau Pharmaceutical Group Recruiting
NCT05456503 PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620 University of Pennsylvania Recruiting
NCT07262645 Near-infrared Light Therapy Device for Mild-Moderate Alzheimer's Disease (NirsCure-03A) Danyang Huichuang Medical Equipment Co., Ltd. Recruiting
NCT07251023 Efficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type Dementia Bigespas LTD Recruiting
NCT06534723 Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate… Sichuan Jishengtang Pharmaceutical Co., Ltd. Recruiting
See all 879 active Alzheimer's Disease trials with filters →
Top Sponsors
Get alerts when Alzheimer's Disease trials change
Status changes, date slips, and new sponsor entrants — detected daily, delivered to your inbox.
Start monitoring free